For research use only. Not for human consumption.
Retatrutide (development code LY3437943) is a novel synthetic 39-amino-acid peptide that acts as a potent triple hormone receptor agonist.
Price range: $90.00 through $300.00
Retatrutide (development code LY3437943) is a novel synthetic 39-amino-acid peptide that acts as a potent triple hormone receptor agonist. It targets three distinct metabolic pathways by activating the GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and GCGR (glucagon) receptors simultaneously.
Triple Receptor Agonism: Studied for its unique multi-target signaling mechanism combining glycemic control (GIP/GLP-1) with direct hepatic and tissue energy expenditure stimulation (Glucagon).
Accelerated Adipose Clearance: Evaluated in advanced metabolic models for driving potent fat loss while helping preserve lean structural tissue.
Appetite & Gastric Motility Regulation: Researched for its dual action of slowing gastric emptying and modulating central nervous system satiety pathways to reduce overall caloric intake.
To provide a single-molecule triple agonist compound for investigating multi-receptor metabolic regulation, energy expenditure mechanics, satiety pathways, and lipid oxidation in laboratory research.
Intended UseLaboratory Research Only
| Property | Details | ||
| Product Name | Retatrutide | ||
| Product Category | Metabolic Peptides & Incretin Mimetics | ||
| Compound Type | Triple GIP / GLP-1 / Glucagon Receptor Agonist | ||
| Primary Goal | Triple-pathway metabolic study, appetite suppression, and targeted lipid oxidation | ||
| Form | Lyophilized powder (vial) | ||
| Storage | Store lyophilized powder at 2°C to 8°C (refrigerated) or -20°C for long-term storage. | ||
| Protect from direct light. | |||
| Weight | N/A |
|---|---|
| Dosage | 10MG, 40MG |
Explore similar research-grade peptides, selected to complement your research needs.
